Conclusions
Autoantibodies to chromatin-associated proteins are frequently present in sera from patients with SLE, and related disorders. Autoantibodies to conformational epitopes may constitute the majority of the immune response to chromatin-associated antigens, suggesting that intact chromatin may be the immunogen in SLE as well as in certain forms of drug-induced lupus (eg. in procainamide-induced lupus). The preferential reactivity of autoantibodies to histones, PCNA, and Ku with antigenic determinants that are exposed on the surface of the native antigens is consistent with this interpretation.
Strikingly, autoantibodies to these antigens frequently bind within or near active or functional sites, such as the DNA binding site of Ku [29], the site of PCNA critical for its role in enhancing DNA synthesis by polymerase delta [52], the posttranslational modification sites of the histones [68], and the catalytic site of poly(ADP-ribose) polymerase [69]. The explanation for the frequent observation that autoantibodies inhibit function is not yet known. It is possible that this phenomenon is related to the generation of autoantibodies by molecular mimicry, and that the functional sites of foreign antigens may crossreact with self antigens having similar functional sites [9]. Alternatively, the targeting of functional sites by autoantibodies may reflect merely a similar requirement for active sites and antibody-recognition sites to be exposed on surface. Features that make a site suitable for interacting with other proteins (eg. enzymes) or nucleic acids (eg DNA binding sites) may also make it more easily recognized by antibodies.
The amino acids critical for autoantibody binding have not, in any of these cases, been shown to be critical to function. Further mapping and/ or mutagenesis studies will be necessary to determine the significance of the targeting of active or functional sites by autoantibodies.
Similar content being viewed by others
References
Tan EM (1982) Adv. Immunol. 33: 167–240
Tan EM (1989) Adv. Immunol. 44: 93–151
Maddison PJ & Reichlin M (1977) Arthritis Rheum. 20: 819–824
Deutscher SL & Keene JD (1988) Proc. Natl. Acad. Sci. USA 85: 3299–3303
vanVenrooij WJ, Hoet R, Hageman B, Mattaj IW & Van dePutte LB (1990) J. Clin. Invest. 86: 2154–2160
Burlingame RW & Rubin RL (1991) J. Clin. Invest. 88: 680–690
Schlomchik MJ, Marshak-Rothstein A, Wolfowicz CB, Rothstein TL & Weigert MG (1987) Nature (Lond.) 328: 805–811
Schlomchik M, Mascelli M, Shan H, Radic MZ, Pisetsky D, Marshak-Rothstein A & Weigert M (1990) J. Exp. Med. 171: 265–298
Chan EK & Tan EM (1987) J. Exp. Med. 166: 1627–1640
Reeves WH (1985) J. Exp. Med. 161: 18–39
Reeves WH (1987) J. Rheumatol 14 (Suppl 13): 97–105
Mimori T & Hardin JA (1986) J. Biol. Chem. 261: 10375–10379
deVries E, vanDriel W, Bergsma WG, Arnberg AC & van derVliet PC (1989) J. Mol. Biol. 208: 65–78
Mimori T, Hardin JA & Steitz JA (1986) J. Biol. Chem. 261: 2274–2278
Francoeur AM, Peebles CL, Gompper PT & Tan EM (1986) J. Immunol. 136: 1648–1653
Chan JYC, Lerman MI, Prabhakar BS, Isozaki O, Santisteban P, Kuppers RC, Oates EL, Notkins AL & Kohn LD (1989) J. Biol. Chem. 264: 3651–3654
Yaneva M & Busch H (1986) Biochemistry 25: 5057–5063
Bravo R & Celis JE (1982) Clin. Chem. 28: 949–954
Stuiver MH, Celis JE & van derVliet PC (1991) FEBS 282: 189–192
Lees-Miller SP, Chen YR & Anderson CW (1990) Mol. Cell. Biol. 10: 6472–6481
Stuiver MH, Coenjaerts FEJ & van derVliet PC (1990) J. Exp. Med. 172: 1049–1054
Amabis JM, Amabis DC, Kaburaki J & Stollar BD (1990) Chromosoma 99: 102–110
Knuth MW, Gunderson SI, Thompson NE, Strasheim LA & Burgess RR (1990) J. Biol. Chem. 265: 17911–17920
Roberts MR, Miskimins WK & Ruddle FH (1989) Cell Regulation 1: 151–164
May G, Sutton C & Gould H (1991) J. Biol. Chem. 266: 3052–3059
Mimori T, Ohosone Y, Hama N, Suwa A, Akizuki M, Homma M, Griffith AJ & Hardin JA (1990) Proc. Natl. Acad. Sci. USA 87: 1777–1781
DePamphilis ML (1988) Cell 52: 635–638
Allaway GP, Vivino AA, Kohn LD, Notkins AL & Prabhakar BS (1989) Biochem. Biophys. Res. Commun. 168: 747–755
Reeves WH, Pierani A, Chou CH, Schmitt J, Knuth MW, Stunnenberg HG & Roeder RG (1991) Mol. Biol. Rep. 15: 115
Reeves WH & Sthoeger ZM (1989) J. Biol. Chem. 264: 5047–5052
Yaneva M, Wen J, Ayala A & Cook R (1989) J. Biol. Chem. 264: 13407–13411
Ma J & Ptashne M (1987) Cell 48: 847–853
Hope IA & Struhl K (1986) Cell 46: 885–894
Prabhakar BS, Allaway GP, Srinivasappa J & Notkins AL (1990) J. Clin. Invest. 86: 1301–1305
Mimori T, Akizuki M, Yamagata H, Inada S, Yoshida S & Homma M (1981) J. Clin. Invest. 68: 611–620
Yaneva M & Arnett FC (1989) Clin. Exp. Immunol. 76: 366–372
Reeves WH, Sthoeger ZM & Lahita RG (1989) J. Clin. Invest. 84: 562–567
Reeves WH, Pierani A, Chou CH, Ng T, Nicastri C, Roeder RG & Sthoeger ZM (1991) J. Immunol. 146: 2678–2686
Wen J & Yaneva M (1990) Mol. Immunol. 27: 973–980
Porges A, Ng T & Reeves WH (1990) J. Immunol. 145: 4222–4228
Almendral JM, Huebsch D, Blundell PA, Macdonald-Bravo H & Bravo R (1987) Proc. Natl. Acad. Sci. USA 84: 1575–1579
So AG & Downey KM (1992) Crit. Rev. Biochem. Mol. Biol. 27: 129–155
Miyachi K, Fritzler MJ & Tan EM (1978) J. Immunol. 121: 2228–2234
Bravo R & Macdonald-Bravo H (1987) J. Cell Biol. 105: 1549–1554
Bravo R & Macdonald-Bravo H (1985) EMBO J. 4: 655–661
Bravo R & Celis JE (1980) J. Cell Biol. 84: 795–802
Celis JE & Celis A (1985) Proc. Natl. Acad. Sci. USA 82: 3262–3266
Bravo R, Frank R, Blundell PA & Macdonald-Bravo H (1987) Nature (Lond.) 326: 515–517
Prelich G, Tan KK, Kostura M, Mathews MB, So AG, Downey KM & Stillman B (1987) Nature (Lond.) 326: 517–520
Prelich G, Kostura M, Marshak DR, Mathews MB & Stillman B (1987) Nature (Lond.) 326: 471–475
Suzuka I, Daidoji H, Matsuoka M, Kadowski KI, Takasaki Y, Nakane PK & Moriuchi T (1989) Proc. Natl. Acad. Sci. USA 86: 3189
Tan CK, Sullivan K, Li XY, Tan EM, Downey KM & So AG (1987) Nucl. Acids Res. 15: 9299–9308
Ogata K, Ogata Y, Takasaki Y & Tan EM (1987) J. Immunol. 139: 2942–2946
Huff JP, Roos G, Peebles CL, Houghten R, Sullivan KF & Tan EM (1990) J. Exp. Med. 172: 419–429
Wu RS, Panusz HT, Hatch CL & Bonner WM (1986) CRC Crit. Rev. Biochem. 20: 201–263
Pettijohn DE (1988) J. Biol. Chem. 263: 12793–12796
Pederson DS, Thomas F & Simpson RT (1986) Annu. Rev. Cell Biol. 2: 117–147
Allan J, Hartman PG, Crane-Robinson C & Aviles FX (1980) Nature (Lond.) 288: 675–679
Monestier M, Fasy TM & Bohm L (1989) Mol. Immunol. 26: 749–758
Suzuki M (1989) EMBO J. 8: 797–804
Churchill MAE & Travers AA (1991) Trends Biochem. Sci. 16: 92–97
Costa O & Monier JC (1986) J. Rheumatol. 13: 722–725
Monestier M, Losman JA, Fasy TM, Debbas ME, Massa M, Albani S, Bohm L & Martini A (1990) Arthritis Rheum. 33: 1836–1841
Gohill J, Cary PD, Couppez M & Fritzler MJ (1985) J. Immunol. 135: 3116–3121
Hardin JA & Thomas JO (1983) Proc. Natl. Acad. Sci. USA 80: 7410–7414
Portanova JP, Arndt RE, Tan EM & Kotzin BL (1987) J. Immunol. 138: 446–451
Portanova JP, Cheronis JC, Blodgett JK & Kotzin BL (1990) J. Immunol. 144: 4633–4640
Goldknopf I & Busch H (1977) Proc. Natl. Acad. Sci. USA 74: 864
Yamanaka H, Willis EH & Carson DA (1989) J. Clin. Invest. 83: 180–186
Author information
Authors and Affiliations
Additional information
This work was supported by Public Health Service grant AR40391 from the National Institutes of Health
Rights and permissions
About this article
Cite this article
Chou, CH., Satoh, M., Wang, J. et al. B-cell epitopes of autoantigenic DNA-binding proteins. Mol Biol Rep 16, 191–198 (1992). https://doi.org/10.1007/BF00464707
Issue Date:
DOI: https://doi.org/10.1007/BF00464707